ArticleGut2025

Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α.

Caorui Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.